Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/51694
Campo DC Valoridioma
dc.contributor.authorBerntssen, M. H.G.en_US
dc.contributor.authorBetancor, M.en_US
dc.contributor.authorCaballero, M. J.en_US
dc.contributor.authorHillestad, M.en_US
dc.contributor.authorRasinger, J.en_US
dc.contributor.authorHamre, K.en_US
dc.contributor.authorSele, V.en_US
dc.contributor.authorAmlund, H.en_US
dc.contributor.authorØrnsrud, R.en_US
dc.date.accessioned2018-11-25T03:01:14Z-
dc.date.available2018-11-25T03:01:14Z-
dc.date.issued2018en_US
dc.identifier.issn0044-8486en_US
dc.identifier.urihttp://hdl.handle.net/10553/51694-
dc.description.abstractThe use of plant-based feeds warrants the supplementation with selenium (Se) to cover the requirement for Atlantic salmon. Depending on its chemical form, Se is a trace element with a narrow range between requirement and toxicity for most vertebrates. Information on safe upper limit for Atlantic salmon feed supplementation is lacking. Atlantic salmon (147 g) were fed a low natural background organic Se diet (0.45 mg Se kg(-1), wet weight (ww)) fortified with 5 graded levels of inorganic sodium selenite (0.45, 5.4, 11.0, 29.4, or 60.0 mg kg(-1) ww) or organic selenomethionine (SeMet) (0.45, 6.2, 16.2, 21, or 39 mg kg(-1) ww), in triplicate for 3 months. Excess Se supplementation was assessed by targeted biomarkers of Se toxicity pathways (e.g. markers of oxidative stress and lipid metabolism), as well as general adverse effect parameters (plasma biochemistry, hematology, liver histopathology, and growth). Safe limits were set by model-fitting the effect data in a dose-response (lower bound) bench mark dose (BMDL) evaluation. Fish fed the two highest selenite levels showed mortality while fish fed SeMet had no mortality. Fish fed 5.4-11 mg selenite kg(-1) feed showed significantly (ANOVA, Tukey's t-test, p < .05) increased liver oxidative stress, as seen from altered hepatic GSH and vitamin E levels, and liver damage as seen from increased plasma ALAT and liver histopathology such as degeneration and focal necrosis. Fish fed SeMet mainly showed liver pathology and kidney dysfunction as seen from altered plasma creatinine and total plasma proteins in fish fed >= 21 mg kg(-1), compared to control. For selenite exposed fish, a safe feed limit (BMDL) was set at 1-2 mg kg(-1) ww feed (daily dose 0.01-0.02 mg kg BW-1 day(-1)), based on plasma ALAT increase, liver vitamin E depletion, and liver histopathology. For SeMet fed fish, the safe feed limit was higher than for selenite with a BMDL of 2.8 mg kg(-1) ww (dose 0.03 mg kg BW-1 day(-1)), based on liver histopathology and plasma creatinine. In conclusion, with regards to fish health, Atlantic salmon seemed to tolerate the supplementation of selenite or SeMet to a level of total selenium of respectively 1-2 or 3 mg kg(-1) feed, respectively, in a high plant-based salmon feed with background levels of 0.45 mg Se kg(-1).en_US
dc.languageengen_US
dc.publisher0044-8486
dc.relation.ispartofAquacultureen_US
dc.sourceAquaculture[ISSN 0044-8486],v. 495, p. 617-630en_US
dc.subject251092 Acuicultura marinaen_US
dc.subject.otherRainbow-Trout Salmoen_US
dc.subject.otherPhysiological Stress-Responseen_US
dc.subject.otherFatty-Acid-Compositionen_US
dc.subject.otherDietary Seleniumen_US
dc.subject.otherOxidative Stressen_US
dc.subject.otherOrganic Seleniumen_US
dc.subject.otherInorganic Seleniumen_US
dc.subject.otherGraded-Levelsen_US
dc.subject.otherBelews Lakeen_US
dc.subject.otherToxicityen_US
dc.titleSafe limits of selenomethionine and selenite supplementation to plant-based Atlantic salmon feedsen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.aquaculture.2018.06.041en_US
dc.identifier.scopus85048749933-
dc.identifier.isi000439123500073-
dc.contributor.authorscopusid6603855136-
dc.contributor.authorscopusid26431740800-
dc.contributor.authorscopusid57209992208-
dc.contributor.authorscopusid22947613100-
dc.contributor.authorscopusid55929492000-
dc.contributor.authorscopusid7004488774-
dc.contributor.authorscopusid55010719200-
dc.contributor.authorscopusid6504817201-
dc.contributor.authorscopusid56117716100-
dc.description.lastpage630en_US
dc.description.firstpage617en_US
dc.relation.volume495en_US
dc.investigacionCienciasen_US
dc.type2Artículoen_US
dc.contributor.daisngid369981-
dc.contributor.daisngid832465-
dc.contributor.daisngid436538-
dc.contributor.daisngid1791991-
dc.contributor.daisngid1685246-
dc.contributor.daisngid127599-
dc.contributor.daisngid1552185-
dc.contributor.daisngid1627284-
dc.contributor.daisngid1361121-
dc.description.notasEmpresa: BioMar AS, Trondheim, Norway Ámbito de la empresa: Internacional no europeaen_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Berntssen, MHG-
dc.contributor.wosstandardWOS:Betancor, M-
dc.contributor.wosstandardWOS:Caballero, MJ-
dc.contributor.wosstandardWOS:Hillestad, M-
dc.contributor.wosstandardWOS:Rasinger, J-
dc.contributor.wosstandardWOS:Hamre, K-
dc.contributor.wosstandardWOS:Sele, V-
dc.contributor.wosstandardWOS:Amlund, H-
dc.contributor.wosstandardWOS:Ornsrud, R-
dc.date.coverdateOctubre 2018en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-BASen_US
dc.description.sjr1,154
dc.description.jcr3,022
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUSA-ONEHEALTH 3: Histología y Patología Veterinaria y Forense (Terrestre y Marina)-
crisitem.author.deptIU de Sanidad Animal y Seguridad Alimentaria-
crisitem.author.deptDepartamento de Morfología-
crisitem.author.orcid0000-0002-2575-0997-
crisitem.author.parentorgIU de Sanidad Animal y Seguridad Alimentaria-
crisitem.author.fullNameCaballero Cansino, María José-
Colección:Artículos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.